The U.S. Food and Drug Administration (FDA) has issued a warning to consumers, healthcare providers, and healthcare facilities not to use Hologic's BioZorb and BioZorb LP radiographic markers.
On October 24 Hologic issued a voluntary recall for all lots of unused BioZorb markers, which are for radiographic marking in soft tissue, including breast tissue.
Any problems with the use of these devices can be reported through the agency's MedWatch Voluntary Reporting form, the FDA said.
